Clinical trial
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus…
NCT00094757 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00094757 |
|---|---|
| Title | An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023) |
| Official title | A Multicenter, Randomized, Double-Blind Study of MK0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Comparator: sitagliptin 100 mg, Comparator: sitagliptin 200 mg, Comparator: placebo, Comparator: pioglitazone |
| Enrollment | 521 |
| Start date | Oct 6, 2004 |
| Primary completion | Aug 17, 2005 |
| Completion | Apr 28, 2006 |
| First posted | Oct 25, 2004 |
| Last update posted | May 30, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: